These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3875380)

  • 1. Evidence that the accumulation of 5-hydroxytryptamine in the liver but not in the brain may cause the hypoglycaemia induced by 5-hydroxytryptophan.
    Endo Y
    Br J Pharmacol; 1985 Jul; 85(3):591-8. PubMed ID: 3875380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression and potentiation of 5-hydroxytryptophan-induced hypoglycaemia by alpha-monofluoromethyldopa: correlation with the accumulation of 5-hydroxytryptamine in the liver.
    Endo Y
    Br J Pharmacol; 1987 Jan; 90(1):161-5. PubMed ID: 3493049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain.
    Löscher W; Pagliusi SR; Müller F
    Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum leptin levels after central and systemic injection of a serotonin precursor, 5-hydroxytryptophan, in mice.
    Yamada J; Ujikawa M; Sugimoto Y
    Eur J Pharmacol; 2000 Oct; 406(1):159-62. PubMed ID: 11011048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The maturational onset of the 5-HT mediated head twitch in mice.
    Eble JP; Goodrich C
    Physiol Behav; 1987; 41(1):47-51. PubMed ID: 3500481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptophan and carbidopa in spontaneously hypertensive rats.
    Itskovitz HD; Werber JL; Sheridan AM; Brewer TF; Stier CT
    J Hypertens; 1989 Apr; 7(4):311-5. PubMed ID: 2786023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central versus peripheral effects on temperature preference and body temperature following alteration of 5-HT in maturing mice.
    Goodrich C; Lechner R; Slone W
    Physiol Behav; 1989 Aug; 46(2):203-9. PubMed ID: 2602460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.
    Magnussen I; Jensen TS; Rand JH; Van Woert MH
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):184-9. PubMed ID: 6175178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of [3H]5-hydroxytryptamine binding sites in chick embryo brain by monoamine oxidase inhibitors or fenfluramine and potentiation by d,l-5-hydroxytryptophan.
    Soblosky JS; DuMontier G; Jeng I
    J Neurochem; 1985 Dec; 45(6):1923-31. PubMed ID: 3932597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigs.
    Luscombe G; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Jun; 32(12):1857-64. PubMed ID: 6192824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan and the control of plasma glucose concentrations in the rat.
    Smith SA; Pogson CL
    Biochem J; 1977 Dec; 168(3):495-506. PubMed ID: 147076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats.
    Lynn-Bullock CP; Welshhans K; Pallas SL; Katz PS
    J Chem Neuroanat; 2004 May; 27(2):129-38. PubMed ID: 15121217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying the effects of 5-hydroxytryptamine and 5-hydroxytryptophan in pancreatic islets. A proposed role for L-aromatic amino acid decarboxylase.
    Lindström P; Sehlin J
    Endocrinology; 1983 Apr; 112(4):1524-9. PubMed ID: 6339207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(11)C]5-HTP and microPET are not suitable for pharmacodynamic studies in the rodent brain.
    Visser AK; Ramakrishnan NK; Willemsen AT; Di Gialleonardo V; de Vries EF; Kema IP; Dierckx RA; van Waarde A
    J Cereb Blood Flow Metab; 2014 Jan; 34(1):118-25. PubMed ID: 24084697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serotonin precursor 5-hydroxytryptophan elevates serum leptin levels in mice.
    Yamada J; Sugimoto Y; Ujikawa M
    Eur J Pharmacol; 1999 Oct; 383(1):49-51. PubMed ID: 10556680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic stimulation of pituitary-adrenal activity in the mouse.
    Meyer JS; Buckholtz NS; Boggan WO
    Neuroendocrinology; 1978; 26(5):312-24. PubMed ID: 150549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of hypoglycaemia and accumulation of 5-hydroxytryptamine in the liver after the injection of mitogenic substances into mice.
    Endo Y
    Br J Pharmacol; 1984 Apr; 81(4):645-50. PubMed ID: 6722393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of administration of 5-hydroxytryptophan and an inhibitor of L-aromatic amino acid decarboxylase on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    Neurochem Res; 1979 Apr; 4(2):277-87. PubMed ID: 313531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice.
    Wilson GA; Furman BL
    Eur J Pharmacol; 1982 Mar; 78(3):263-70. PubMed ID: 7040087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.